Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP
Go back to Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP| CEMPRA (NASDAQ: CEMP) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $34.24 | |||
| Open | $0.86 | 52 Week Low | $5.70 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $-1.25 | |||
| Volume | 103,715 | |||||
